Medistep Healthcare Limited (NSE:MEDISTEP)
India flag India · Delayed Price · Currency is INR
18.20
+0.05 (0.28%)
At close: Nov 13, 2026

Medistep Healthcare Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
731.36708.31496.55390.72276.4776.24
Revenue Growth
30.74%42.65%27.09%41.33%262.61%-
Gross Profit
93.0190.0560.9648.7915.215.71
Operating Income
86.5982.4355.6845.312.742.96
Net Income
61.1659.8341.4429.149.211.9
Earnings Per Share
4.304.684.0119.96--
EPS Growth
-0.07%16.75%-79.92%---

Revenue by Segment

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '25 Mar '24 Mar '23 Mar '22
Manufacturing
155.41131.62---
Trading
552.9364.9374.57276.4776.24
Total
708.31496.5574.57276.4776.24

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
7.016.1313.10.11.240.31
Total Debt
51.2451.816.353.265.3210.57
Net Cash (Debt)
-44.23-45.686.75-3.16-4.08-10.26
Net Cash Growth
------
Net Cash Per Share
-3.11-3.570.65-2.17--

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--194.770.21-69.634.42-
Capital Expenditures
--0.09--1.52--
Free Cash Flow
--194.860.21-71.154.42-
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
12.72%12.71%12.28%12.49%5.50%7.49%
Operating Margin
11.84%11.64%11.21%11.59%4.61%3.88%
Pretax Margin
11.19%11.29%11.15%11.38%4.45%3.32%
Profit Margin
8.36%8.45%8.35%7.46%3.33%2.49%
FCF Margin
--27.51%0.04%-18.21%1.60%-

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
4.233.92----
PS Ratio
0.350.33----